trans-4-Hydroxy-2-hexenal: a reactive metabolite from the macrocyclic pyrrolizidine alkaloid senecionine.
The toxicity of macrocyclic pyrrolizidine alkaloids in the livers of man and animals has been attributed to the formation of reactive pyrroles from dihydropyrrolizines. Now a novel metabolite, trans-4-hydroxy-2-hexenal, has been isolated from the macrocyclic pyrrolizidine alkaloid senecionine, in an in vitro hepatic microsomal system. Other alkenals such as trans-4-hydroxy-2-nonenal have previously been isolated from microsomal systems when treated with halogenated hydrocarbons or subjected to lipid peroxidation. The in vivo pathology caused by trans-4-hydroxy-2-hexenal appears to be identical to that previously attributed to reactive pyrroles. There are similarities between the toxic effects of this alkenal and those of centrilobular hepatotoxins such as CCl4 and other alkenals formed during lipid peroxidation.
D000447:Aldehydes / Q000378:metabolism* / Q000633:toxicity; D000818:Animals; D001711:Biotransformation; D056486:Chemical and Drug Induced Liver Injury; D066298:In Vitro Techniques; D007275:Injections, Intravenous; D008054:Lipid Peroxides / Q000096:biosynthesis; D008107:Liver Diseases / Q000473:pathology; D051379:Mice; D008862:Microsomes, Liver / Q000378:metabolism; D009336:Necrosis / Q000139:chemically induced; D011169:Portal Vein; D011763:Pyrrolizidine Alkaloids / Q000378:metabolism* / Q000633:toxicity; D051381:Rats
D000447:Aldehydes; D008054:Lipid Peroxides; D011763:Pyrrolizidine Alkaloids; C045934:4-hydroxy-2-hexenal; C009237:senecionine